23 May 2013
Keywords: ark, therapeutics, reports, progress, glioma, gene, therapy
Article | 11 April 2001
Anglo-Finnish biotechnology company Ark Therapeutics has reported thatits EG009 gene therapy has been shown to double survival times in a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.